Health Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial November 20, 2024 …
Health 2 health stocks are buys. They’ve been beaten up enough on Trump’s RFK Jr. pick for HHS November 19, 2024 …
Education Billionaire investors were torn on Alphabet, Amazon. How they traded 5 portfolio stocks November 16, 2024 …
Health How we’re thinking about Eli Lilly after Trump picked obesity-drug critic RFK Jr. to run HHS November 16, 2024 …
Finance Stocks making the biggest moves midday: Palantir, Moderna, Ulta Beauty, Alibaba and more November 16, 2024 …
Health Here’s a rapid-fire update on what Trump will mean for all 33 portfolio stocks November 15, 2024 …
Education This fund has outperformed the S&P 500 over the past 5 years. Here’s how November 14, 2024 …
Health Amgen stock falls as analysts mull over weight loss drug’s bone density data November 13, 2024 …
Education Here’s why Eli Lilly bounced back, plus mega-caps lag while staples stocks rise November 10, 2024 …
Health Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca November 8, 2024 …
Health Eli Lilly’s Zepbound and Mounjaro are no longer in shortage. Here’s where their sales still disappointed November 7, 2024 …
Health Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance November 7, 2024 …
Business, Startups Why half of all workers may struggle to get weight-loss drug health insurance coverage November 7, 2024 …
Health Novo Nordisk’s Ozempic and Wegovy now available in the U.S. after shortages, FDA says November 7, 2024 …
